In the course of our screening for new anthracycline antibiotics equally active against both parental and doxorubicin-resistant cell lines, candidates were discovered in the broth filtrate of strain H1715MY2 isolated from the soil sample collected at Matsumoto city in Nagano prefecture. Five anthracycline antibiotics were isolated; four of them were identified to be cinerubins A2), B2), pyrraculomycin3) and 1-hydroxysulfurmycin B4), whereas one of them was found to be a novel cinerubin congener, being named cinerubin R.
In this paper, the isolation, structural elucidation and biological properties of the anthracyclines produced by strain H1715MY2as well as the taxonomic studies on the producing organism are reported.
Materials and Methods

General
UVspectra were examined with a Hitachi 124 spectrophotometer, 1 cm light pass, using methanol as a solvent. 1H NMR and 13C NMR spectra were measured in CDC13on a Jeol JNM-GX500 spectrometer using tetramethylsilan (TMS) as the internal reference. Mass spectra were determined on a Jeol JMS-SX102 spectrometer.
Microorganisms
Strain H1715MY2 was isolated from the soil sample collected in Matsumoto city, Nagano prefecture, Japan.
Taxonomic Studies
Growth characteristics and carbohydrate utilization were determined according to the methods of Shirling and Gottlieb5) . Morphology of spore chains was observed after incubation on ISP media at 27°C for 14 days. The Color Harmony Manual (4th Ed., 1958, Container Corporation of America, Chicago, Illinois) was used to identify the color of mycelia and soluble pigments. Spores were observed with a OCT. 1992 scanning electron microscope (Model S-510, Hitachi Co., Ltd.). Diaminopimelic acid isomers of whole-cell hydrolysate were analyzed by the method of Becker et al.6\ Fermentation Strain H1715MY2 was cultured in 500-ml Erlenmeyer flasks each containing 100ml of a seed medium composed ofmaltose 1% and yeast extract 0.4% (adjusted to pH 7.0 before sterilization).
After 20 hours of incubation at 27°C on a rotary shaker, 1-ml portion of the culture was inoculated into 500-ml Erlenmeyer flasks containing 100ml of a production mediumconsisting of soyameal 2%, soluble starch 1.5%, glucose 1%, Ebios 0.5% (Tanabe Seiyaku Co., Ltd.), CaCO3 0.3% and NaCl 0.25% (adjusted to pH 7.6 before sterilization).
The fermentation was carried out at 27°C for 4 days on a rotary shaker (160rpm).
Antimicrobial Activity
The in vitro antimicrobial activity was determined on glucose-nutrient agar by the 2-fold serial dilution method. 
In Vitro Antitumor Activitv
The cells were cultured in an appropriate mediumat 3 x 104/ml (L5178Y and P 388 cells) or 5 x 104/ml (K562 cells) in the absence or the presence of antibiotic for 3 days. The number of cells were counted in a Coulter counter (Coulter Electronics Ltd., Beds, England). The resistance factor (RF) against individual antibiotics was defined as a ratio of IC50's for the resistant cells and the parental cells. Mature spore chains consisted of 10~20 or more spores in the forms of hook and loop ( Fig. 1) . The smooth-surfaced spores shaped oval and measured 0.6~0.7 x 1.0~1.2/mi (Fig. 2) . The whole-cell hydrolysate contained the L,L-isomer of diaminopimelic acid corresponding to cell wall typeI.
Results and Discussion
The cultural and physiological characteristics are shown in Tables 1 and 2 , respectively. Based on the taxonomic properties described above, strain H1715MY2 is considered to belong to the genus Streptomyces and to be a strain of the gray color series of the Pridham and Tresner grouping11}. By consulting Bergey's Manual12) and the literatures13~16), Streptomyces eurythermus was most closely related to strain H1715MY2. These two strains were indistinguishable from each other with respect to the colors of aerial hypha on various media (gray series), spore chain morphology (section Rectiflexibiles), spore surface structure (smooth), melanin production and carbon utilization. Therefore, strain H 171 5MY2 Extraction A flow diagram for the extraction of anthracyclines is shown in Fig. 3 . OCT. 1992 (Fig. 4) . Finally,^y-pyrromycinone (1-1) and five anthracycline antibiotics (II-1, III-l, III-2, IV-1 and IV-2) were isolated. Based on the 13C NMRspectra and the physico-chemical properties shown in Tables 4 and 5 Fig. 5 ). Since III-2, which is a novel anthracycline, shared the common aglycone £-pyrromycinone with the cinerubin congeners II-1 , IV-1 and IV-2, it was designated as cinerubin R.
Structural Elucidation of Cinerubin R The molecular formula was established to be C42H51NO15 by high resolution FAB-MS(m/z 810.3366 MH+, calcd 810.3337). The *H NMRspectrum of cinerubin R showed signals due to three phenolic hydroxyl groups (3 12.96, 12.80, 12.23 ), a singlet aromatic methine (3 7.72) , two doublet aromatic methines (5 7.31, 7. 29; /=9.0Hz), a broad doublet methine (S 5.27,.7=4.0Hz), a singlet methine (3 4.12 m; 3 1.51, m; 3 1.09, t, 3H,.7=7.5 Hz), which were assignable to e-pyrromycinone. In addition, the presence of three anomeric protons (3 5.54, brd, .7=2.5 Hz; 3 5.23, d, .7=3.5 Hz; 3 4.93 , brs) with a-configurations, cis olefinic protons (3 6.87 , dd, /= 10.5, 3.5Hz; 6.08, d, /= 10.5Hz) and an iV-dimethyl group (<5 2.19, brs, 6H) indicated that cinerubin R contains a trisaccharide moiety including a dehydro sugar and a dimethylamino sugar.
Hydrolysis of cinerubin R with 0. 1 n HC1 at 85°C for 30 minutes gave £-pyrromycinone, rhodosamine, rhodinose and aculose. These components were identified by silica gel TLCdeveloped with CHC13-MeOH (20: 1) or BuOH-AcOH-H2O(4: 1 : 1) by comparison with authentic samples, which were obtained by hydrolysis of cinerubin A1] and vineomycin A1 (P-1894B)19'20). The 13C NMRspectrum of cinerubin R showed signals due to e-pyrromycinone and three sugar components. Assignments of the signals were carried out by comparison with the spectral data of mussetamycin (deoxyfucosyl-rhodosaminyl-£-pyrromycinone)2 1) and vineomycin At. The FAB-MSrevealed a fragment peak at m/z 586 corresponding to pyrromycin (rhodosaminyl-£-pyrromycinone) derived from the loss of aculosyl-rhodinose.
Thus, the structure of cinerubin R was established to be 4''-aculosyl-4'-rhodinosyl-7-rhodosammyle-pyrromycinone.
Antimicrobial Activity The minimum inhibitory concentrations (MICs) of the anthracyclines produced by strain H17 1 5MY2 for a variety of organisms including bacteria, yeasts and fungi are shown in Table 6 . All antibiotics inhibited the growth of Gram-positive bacteria but little or no effect was observed against Gram-negative bacteria, yeasts and fungi.
Amongthe cinerubin congeners, pyrraculomycin showed the highest activity against Gram-positive bacteria. Cinerubin R is less potent than pyrraculomycin, but superior to cinerubins A and B.
In Vitro Antitumor Activity The anthracyclines produced by strain H1715MY2 were examined for their in vitro antitumor activity and the results are shown in Table 7 . Doxorubicin (Kyowa Hakko Kogyo Co., Ltd.) and daunorubicin (Meiji Seika Co., Ltd.) served as references.
L5178Y/ADM, P388/ADM, K562/ADMand K562/VCR daunorubicin, whereas those for the cinerubin congeners and 1-hydroxysulfurmycin B were less than 6. The present in vitro results might indicate the possibility of overcoming in vivo resistance of mdr-phenotype tumor cells with these anthracyclines. The mechanism by which cinerubins reverse the function of P-glycoprotein which plays a central role in mdr cells will be reported elsewhere.
